Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial

Date Issued
2019
Author(s)
Michels, Sebastian
Massutí, Bartomeu
Franklin, Jeremy
Sebastian, Martin
Felip, Enriqueta
Grohé, Christian
Rodriguez-Abreu, Delvys
Abdulla, Diana S.Y.
Bischoff, Helge
Brandts, Christian
Carcereny, Enric
Corral, Jesús
Dingemans, Anne-Marie C.
Pereira, Eva
Fassunke, Jana
Fischer, Rieke N.
Gardizi, Masyar
Heukamp, Lukas
Insa, Amelia
Kron, Anna
Menon, Roopika
Persigehl, Thorsten
Reck, Martin
Riedel, Richard
Rothschild, Sacha I.
Scheel, Andreas H.
Scheffler, Matthias
Schmalz, Petra
Smit, Egbert F.
Limburg, Meike
Provencio, Mariano
Karachaliou, Niki
Merkelbach-Bruse, Sabine
Hellmich, Martin
Nogova, Lucia
Büttner, Reinhard
Rosell, Rafael
Wolf, Jürgen
DOI
10.1016/j.jtho.2019.03.020